CPS Practice Point
The Committee to Advise on Tropical Medicine and Travel (CATMAT) – a reference for Canadian paediatricians Charles PS Hui; Canadian Paediatric Society, Infectious Diseases and Immunization Committee
Français en page 439
CPS Hui; Canadian Paediatric Society, Infectious Diseases and Immunization Committee. The Committee to Advise on Tropical Medicine and Travel (CATMAT) – a reference for Canadian paediatricians. Paediatr Child Health 2015;20(8):437-440.
Le Comité consultatif de la médecine tropicale et de la médecine des voyages (CCMTMV) – une référence pour les pédiatres canadiens
The Committee to Advise on Tropical Medicine and Travel (CATMAT) is a federal government committee with wide representation in the fields of travel medicine and infectious diseases. They produce evidence-based statements on tropical and travel medicine for Canadian clinicians, including paediatric content ensured by the involvement of paediatric experts and a liaison member from the Canadian Paediatric Society. Links to all of the active statements are provided in the present practice point, with the aim of making Canadian health care providers more aware of this excellent resource. CATMAT statements of special interest to clinicians who deal with children address paediatric travellers, international adoption, personal protective measures to prevent arthropod bites, fever in the returning traveller, malaria, injury risk and travel, and guidelines for the practice of travel medicine.
Le Comité consultatif de la médecine tropicale et de la médecine des voyages (CCMTMV) est un comité du gouvernement fédéral formé de nombreux représentants dans les domaines de la médecine des voyages et des maladies infectieuses. Il produit des déclarations fondées sur des données probantes axées sur la médecine tropicale et la médecine des voyages pour les cliniciens canadiens. Le contenu pédiatrique est assuré par des experts en pédiatrie et un représentant de la Société canadienne de pédiatrie. Les liens vers toutes les déclarations en vigueur figurent dans le présent point de pratique afin de mieux faire connaître cette excellente ressource aux dispensateurs de soins canadiens. Les déclarations du CCMTMV qui présentent un intérêt particulier pour les cliniciens qui s’occupent d’enfants traitent des jeunes voyageurs, de l’adoption internationale, des mesures de protection personnelle pour prévenir les morsures d’arthropodes, de la fièvre chez le voyageur de retour au pays, du paludisme, des risques de blessures chez les voyageurs et des lignes directrices pour la pratique en médecine santé-voyage.
Key Words: CATMAT; Traveller health; Tropical disease; VFR
T
he Committee to Advise on Tropical Medicine and Travel (CATMAT) was formed in 1990, with a mandate to provide recommendations relating to the prevention and treatment of infectious diseases, and other health hazards that may be encountered by Canadian travellers outside of Canada. CATMAT was also mandated to suggest mechanisms for the wider dissemination and use of such recommendations, and to advise of research priorities in tropical medicine and travel health. This federal government committee is part of the Travel and Migration Health division of the Public Health Agency of Canada, and reports to the assistant deputy minister, Infectious Disease Prevention and Control branch. The committee comprises members with expertise in travel and tropical medicine, and liaisons representing the Association of Medical Microbiology and Infectious Diseases Canada, and the Canadian Paediatric Society, among others. Quality paediatric content is ensured by having paediatricians as core members and a strong liaison relationship with the Canadian Paediatric Society.
CATMAT produces evidence-based statements that are published in the Canada Communicable Diseases Report (Table 1) and on the CATMAT website (www.phac-aspc.gc.ca/tmp-pmv/ catmat-ccmtmv/index-eng.php). New evidence is reviewed annually and statements are regularly updated in order of priority. The “Statement on Pediatric Travellers” outlines the risks for travel in different age groups, travel planning, safety and security, infectious and noninfectious issues, personal protective measures and travel-related immunizations. Statements of particular interest to Canadian paediatricians include those on international adoption, personal protective measures to prevent arthropod bites, fever in the returning traveller, malaria, risk of injury and travel, and guidelines for the practice of travel medicine (Table 1). Acknowledgement: This practice point has been reviewed by the Community Paediatrics Committee of the Canadian Paediatric Society.
Correspondence: Canadian Paediatric Society, 100-2305 St Laurent Boulevard, Ottawa, Ontario K1G 4J8. E-mail [email protected], website www.cps.ca Paediatr Child Health Vol 20 No 8 November/December 2015
©2015 Canadian Paediatric Society. All rights reserved
437
CPS Practice Point
Table 1 Committee to Advise on Tropical Medicine and Travel (CATMAT) statements and recommendations (Adapted from CATMAT) Subject
Title
Year
Arthropod bites
Statement on Personal Protective Measures to Prevent Arthropod Bites – Update
2012
Cruise ship travel
Statement on Cruise Ship Travel
2005
Dengue fever
Statement on Dengue
2009
Fever
Fever in the Returning International Traveller
2011
Hepatitis
Summary of the Recommendations for the Prevention of Viral Hepatitis during Travel
2014
Statement on Hepatitis Vaccines for Travellers
2008
High-altitude sickness
Statement on High-altitude Illnesses
2007
The immunocompromised traveller
The Immunocompromised Traveller
2007
Injury risk
Statement on Risk of Injury and Travel
2010
International adoption
Statement on International Adoption
2010
Japanese encephalitis
Statement on Protection Against Japanese Encephalitis
2011
Jet lag
Travel Statement on Jet Lag (external link)
2003
Malaria
Canadian Recommendations for the Prevention and Treatment of Malaria among International Travellers • Full statement (external link) • Prevention summary • Diagnosis and treatment summary • Special host summary • Malaria risk and recommended chemoprophylaxis by geographic area • Drugs for the treatment and prevention of malaria
2014
Meningococcal disease
Statement on Meningococcal Disease and the International Traveller
2015
Motion sickness
Statement on Motion Sickness (external link)
2003
Older travellers
Statement on Older Travellers
2011
Pediatric travellers
Statement on Pediatric Travellers
2010
Polio
Statement on Poliovirus and the International Traveller
2014
Pregnancy
Statement on Pregnancy and Travel
2010
• Correction Notice
2014
Rabies
Statement on Travellers and Rabies Vaccine (external link)
2002
Sexually transmitted infections
Statement on Travellers and Sexually Transmitted Infections
2006
Tick-borne encephalitis
Statement on Tick-borne Encephalitis
2006
Travel medicine resources
Travel Medicine Resources for Canadian Practitioners
2015
Travel medicine practice
Guidelines for the Practice of Travel Medicine
2009
Travellers’ diarrhea
Statement on Travellers’ Diarrhea
2015
Travellers’ diarrhea (persistent)
Statement on Persistent Diarrhea in the Returned Traveller
2006
Tuberculosis
Risk Assessment and Prevention of Tuberculosis among Travellers
2009
Typhoid
Statement on International Travellers and Typhoid
2014
• Summary • Full statement (external link) Visiting friends and relatives (VFRs)
Statement on International Travellers who Intend to Visit Friends and Family
2015
• Full statement • Summary Yellow fever
Statement for Travellers and Yellow Fever
2013
CPS INFECTIOUS DISEASES AND IMMUNIZATION COMMITTEE Members: Natalie A Bridger MD; Shalini Desai MD; Ruth Grimes MD (Board Representative); Charles PS Hui MD (past member); Timothy Mailman MD; Joan L Robinson MD (Chair); Marina Salvadori MD (past member); Otto G Vanderkooi MD Liaisons: Upton D Allen MBBS, Canadian Pediatric AIDS Research Group; Tobey Audcent MD, Committee to Advise on Tropical Medicine and Travel (CATMAT), Public Health Agency of Canada; Carrie Byington MD, Committee on Infectious Diseases, American Academy of Pediatrics; Rhonda Kropp BScN MPH, Public Health Agency of Canada; Nicole Le Saux MD, Immunization Monitoring Program, ACTive (IMPACT); Dorothy L Moore MD, National Advisory Committee on Immunization (NACI); Patricia Mousmanis MD, College of Family Physicians of Canada Consultant: Noni E MacDonald MD Principal author: Charles PS Hui MD The recommendations in this statement do not indicate an exclusive course of treatment or procedure to be followed. Variations, taking into account individual circumstances, may be appropriate. All Canadian Paediatric Society position statements and practice points are reviewed on a regular basis. Retired statements are removed from the website. Please consult the Position Statements section of the CPS website (www.cps.ca) for the full-text, current version.
438
Paediatr Child Health Vol 20 No 8 November/December 2015
The Committee to Advise on Tropical Medicine and Travel (CATMAT) – a reference for Canadian paediatricians Charles PS Hui; Canadian Paediatric Society, Infectious Diseases and Immunization Committee
Français en page 439
CPS Hui; Canadian Paediatric Society, Infectious Diseases and Immunization Committee. The Committee to Advise on Tropical Medicine and Travel (CATMAT) – a reference for Canadian paediatricians. Paediatr Child Health 2015;20(8):437-440.
Le Comité consultatif de la médecine tropicale et de la médecine des voyages (CCMTMV) – une référence pour les pédiatres canadiens
The Committee to Advise on Tropical Medicine and Travel (CATMAT) is a federal government committee with wide representation in the fields of travel medicine and infectious diseases. They produce evidence-based statements on tropical and travel medicine for Canadian clinicians, including paediatric content ensured by the involvement of paediatric experts and a liaison member from the Canadian Paediatric Society. Links to all of the active statements are provided in the present practice point, with the aim of making Canadian health care providers more aware of this excellent resource. CATMAT statements of special interest to clinicians who deal with children address paediatric travellers, international adoption, personal protective measures to prevent arthropod bites, fever in the returning traveller, malaria, injury risk and travel, and guidelines for the practice of travel medicine.
Le Comité consultatif de la médecine tropicale et de la médecine des voyages (CCMTMV) est un comité du gouvernement fédéral formé de nombreux représentants dans les domaines de la médecine des voyages et des maladies infectieuses. Il produit des déclarations fondées sur des données probantes axées sur la médecine tropicale et la médecine des voyages pour les cliniciens canadiens. Le contenu pédiatrique est assuré par des experts en pédiatrie et un représentant de la Société canadienne de pédiatrie. Les liens vers toutes les déclarations en vigueur figurent dans le présent point de pratique afin de mieux faire connaître cette excellente ressource aux dispensateurs de soins canadiens. Les déclarations du CCMTMV qui présentent un intérêt particulier pour les cliniciens qui s’occupent d’enfants traitent des jeunes voyageurs, de l’adoption internationale, des mesures de protection personnelle pour prévenir les morsures d’arthropodes, de la fièvre chez le voyageur de retour au pays, du paludisme, des risques de blessures chez les voyageurs et des lignes directrices pour la pratique en médecine santé-voyage.
Key Words: CATMAT; Traveller health; Tropical disease; VFR
T
he Committee to Advise on Tropical Medicine and Travel (CATMAT) was formed in 1990, with a mandate to provide recommendations relating to the prevention and treatment of infectious diseases, and other health hazards that may be encountered by Canadian travellers outside of Canada. CATMAT was also mandated to suggest mechanisms for the wider dissemination and use of such recommendations, and to advise of research priorities in tropical medicine and travel health. This federal government committee is part of the Travel and Migration Health division of the Public Health Agency of Canada, and reports to the assistant deputy minister, Infectious Disease Prevention and Control branch. The committee comprises members with expertise in travel and tropical medicine, and liaisons representing the Association of Medical Microbiology and Infectious Diseases Canada, and the Canadian Paediatric Society, among others. Quality paediatric content is ensured by having paediatricians as core members and a strong liaison relationship with the Canadian Paediatric Society.
CATMAT produces evidence-based statements that are published in the Canada Communicable Diseases Report (Table 1) and on the CATMAT website (www.phac-aspc.gc.ca/tmp-pmv/ catmat-ccmtmv/index-eng.php). New evidence is reviewed annually and statements are regularly updated in order of priority. The “Statement on Pediatric Travellers” outlines the risks for travel in different age groups, travel planning, safety and security, infectious and noninfectious issues, personal protective measures and travel-related immunizations. Statements of particular interest to Canadian paediatricians include those on international adoption, personal protective measures to prevent arthropod bites, fever in the returning traveller, malaria, risk of injury and travel, and guidelines for the practice of travel medicine (Table 1). Acknowledgement: This practice point has been reviewed by the Community Paediatrics Committee of the Canadian Paediatric Society.
Correspondence: Canadian Paediatric Society, 100-2305 St Laurent Boulevard, Ottawa, Ontario K1G 4J8. E-mail [email protected], website www.cps.ca Paediatr Child Health Vol 20 No 8 November/December 2015
©2015 Canadian Paediatric Society. All rights reserved
437
CPS Practice Point
Table 1 Committee to Advise on Tropical Medicine and Travel (CATMAT) statements and recommendations (Adapted from CATMAT) Subject
Title
Year
Arthropod bites
Statement on Personal Protective Measures to Prevent Arthropod Bites – Update
2012
Cruise ship travel
Statement on Cruise Ship Travel
2005
Dengue fever
Statement on Dengue
2009
Fever
Fever in the Returning International Traveller
2011
Hepatitis
Summary of the Recommendations for the Prevention of Viral Hepatitis during Travel
2014
Statement on Hepatitis Vaccines for Travellers
2008
High-altitude sickness
Statement on High-altitude Illnesses
2007
The immunocompromised traveller
The Immunocompromised Traveller
2007
Injury risk
Statement on Risk of Injury and Travel
2010
International adoption
Statement on International Adoption
2010
Japanese encephalitis
Statement on Protection Against Japanese Encephalitis
2011
Jet lag
Travel Statement on Jet Lag (external link)
2003
Malaria
Canadian Recommendations for the Prevention and Treatment of Malaria among International Travellers • Full statement (external link) • Prevention summary • Diagnosis and treatment summary • Special host summary • Malaria risk and recommended chemoprophylaxis by geographic area • Drugs for the treatment and prevention of malaria
2014
Meningococcal disease
Statement on Meningococcal Disease and the International Traveller
2015
Motion sickness
Statement on Motion Sickness (external link)
2003
Older travellers
Statement on Older Travellers
2011
Pediatric travellers
Statement on Pediatric Travellers
2010
Polio
Statement on Poliovirus and the International Traveller
2014
Pregnancy
Statement on Pregnancy and Travel
2010
• Correction Notice
2014
Rabies
Statement on Travellers and Rabies Vaccine (external link)
2002
Sexually transmitted infections
Statement on Travellers and Sexually Transmitted Infections
2006
Tick-borne encephalitis
Statement on Tick-borne Encephalitis
2006
Travel medicine resources
Travel Medicine Resources for Canadian Practitioners
2015
Travel medicine practice
Guidelines for the Practice of Travel Medicine
2009
Travellers’ diarrhea
Statement on Travellers’ Diarrhea
2015
Travellers’ diarrhea (persistent)
Statement on Persistent Diarrhea in the Returned Traveller
2006
Tuberculosis
Risk Assessment and Prevention of Tuberculosis among Travellers
2009
Typhoid
Statement on International Travellers and Typhoid
2014
• Summary • Full statement (external link) Visiting friends and relatives (VFRs)
Statement on International Travellers who Intend to Visit Friends and Family
2015
• Full statement • Summary Yellow fever
Statement for Travellers and Yellow Fever
2013
CPS INFECTIOUS DISEASES AND IMMUNIZATION COMMITTEE Members: Natalie A Bridger MD; Shalini Desai MD; Ruth Grimes MD (Board Representative); Charles PS Hui MD (past member); Timothy Mailman MD; Joan L Robinson MD (Chair); Marina Salvadori MD (past member); Otto G Vanderkooi MD Liaisons: Upton D Allen MBBS, Canadian Pediatric AIDS Research Group; Tobey Audcent MD, Committee to Advise on Tropical Medicine and Travel (CATMAT), Public Health Agency of Canada; Carrie Byington MD, Committee on Infectious Diseases, American Academy of Pediatrics; Rhonda Kropp BScN MPH, Public Health Agency of Canada; Nicole Le Saux MD, Immunization Monitoring Program, ACTive (IMPACT); Dorothy L Moore MD, National Advisory Committee on Immunization (NACI); Patricia Mousmanis MD, College of Family Physicians of Canada Consultant: Noni E MacDonald MD Principal author: Charles PS Hui MD The recommendations in this statement do not indicate an exclusive course of treatment or procedure to be followed. Variations, taking into account individual circumstances, may be appropriate. All Canadian Paediatric Society position statements and practice points are reviewed on a regular basis. Retired statements are removed from the website. Please consult the Position Statements section of the CPS website (www.cps.ca) for the full-text, current version.
438
Paediatr Child Health Vol 20 No 8 November/December 2015
